The AUC of Prdx4 was 1.000 in the combined data cohort and 0.917 in the GSE3644 cohort, indicating the potential of the Prdx4 gene as a biomarker to predict the occurrence of AP. The gene discussed is PRDX4; the disease is alkaline phosphatase measurement.